The 5-yr survival rate for the adenocarcinoma patients was 19 vs. 7% in the remainder of patients. Of 39 patients referred for surgery, 37 had lung resections and their 5-yr survival rate was 42%. Post-operative staging showed 48% in Stage Ⅰ, 27% in Stage Ⅱ and 24% in Stage Ⅲ...
Adenocarcinoma of the lung — clinical features and survival Four thousand patients were registered by the Edinburgh Lung Cancer Group in 1981-1987; 9.5%had adenocarcinoma. Of these, 102 patients with pathological confirmation of the diagnosis, presenting to one hospital group in Edinburgh, were r....
Lung cancer is the leading cause of cancer-related death worldwide, and non-small cell lung cancer (NSCLC) accounts for approximately 85% of all types of lung cancers.1NSCLC is typically diagnosed at advanced stages, resulting in a poor 5-year survival rate of less than 15%.2Intratumoral h...
Lung cancer, with a 5-year overall survival rate of 15%, is a predominant cause of cancer-related deaths among males1. Approximately 80% of lung cancers are non-small-cell lung cancers (NSCLCs)2. The two main types of NSCLCs are lung adenocarcinoma (LUAD) and lung squamous cell carcino...
Lung cancer is the most common cause of cancer-related deaths worldwide [1]. Five-year survival rate of lung cancer varies from 4 to 17%. Non-small cell lung cancer (NSCLC) account for about 80 to 85% of total lung cancer cases, and lung adenocarcinoma (LUAD) is the most common sub...
Pulmonary adenocarcinoma is now the most common type of lung cancer. The morphological and molecular classification of pulmonary adenocarcinoma has undergone significant changes in recent years, resulting in a classification scheme more in tune with patient prognosis and survival. The tumor staging system...
Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma. Eur J Cancer. 2017;86:15–27. Article PubMed Google Scholar Petitprez F, et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature. 2020;...
Lung cancer is one of the most common causes of cancer-related death [1], and the 5-year survival rate for patients with lung cancer is only 16.8% [2]. Non-small cell lung cancers (NSCLCs) account for 85% of all cases [3], among which lung adenocarcinoma is the most common histolo...
Furthermore, lung adenocarcinoma is an important lung cancer subtype that has attracted increasing attention from researchers2,3. Due to the 5-year survival rate of lung adenocarcinoma being comparatively low, thus, improving its clinical prognosis is one of the main goals of clinical workers and ...
The survival rates for different combinations of CCL19 and CCL21 mRNA expression with CCR7 mRNA expression in the lung cancer specimens were examined. A total of 120 patients were divided into four groups according to the median values of CCR7 and CCL19 mRNA expression status in the tumour (CC...